<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>AIMS/HYPOTHESIS: Type 1 and type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> are characterised by a beta cell deficit </plain></SENT>
<SENT sid="1" pm="."><plain>Islet <z:mpath ids='MPATH_134'>hyperplasia</z:mpath> has been described in patients with <z:hpo ids='HP_0002044'>Zollinger-Ellison syndrome</z:hpo> secondary to <z:e sem="disease" ids="C0017150" disease_type="Neoplastic Process" abbrv="">gastrin-producing tumours</z:e> (<z:e sem="disease" ids="C0017150" disease_type="Neoplastic Process" abbrv="">gastrinomas</z:e>), and gastrin therapy has increased beta cell mass in rodents and human islets in vitro </plain></SENT>
<SENT sid="2" pm="?"><plain>In the present studies we addressed the following questions: (1) In pancreas specimens from <z:e sem="disease" ids="C0017150" disease_type="Neoplastic Process" abbrv="">gastrinoma</z:e> cases, is the fractional beta cell area increased </plain></SENT>
<SENT sid="3" pm="?"><plain>(2) If so, is this restricted to <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumour</z:e>-adjacent islets or also present in <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumour</z:e>-distant islets </plain></SENT>
<SENT sid="4" pm="?"><plain>(3) Is new beta cell formation (beta cell replication and islet neogenesis) increased and beta cell <z:mpath ids='MPATH_3'>apoptosis</z:mpath> decreased in pancreas specimens from <z:e sem="disease" ids="C0017150" disease_type="Neoplastic Process" abbrv="">gastrinoma</z:e> cases </plain></SENT>
<SENT sid="5" pm="."><plain>METHODS: Pancreas was obtained at surgery from four patients with <z:hpo ids='HP_0002044'>Zollinger-Ellison syndrome</z:hpo> caused by <z:e sem="disease" ids="C1368066" disease_type="Neoplastic Process" abbrv="">pancreatic gastrinomas</z:e> and 15 control subjects at autopsy </plain></SENT>
<SENT sid="6" pm="."><plain>RESULTS: Islet fractional beta cell area (p&lt;0.001), islet size (p&lt;0.001) and beta cell replication (Ki67 staining) (p&lt;0.05) were increased in islets adjacent to the <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumours</z:e>, but not in <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumour</z:e>-distant pancreas, compared with control subjects </plain></SENT>
<SENT sid="7" pm="."><plain>We did not observe any differences in beta cell <z:mpath ids='MPATH_3'>apoptosis</z:mpath> or in the number of insulin-positive cells in ducts either adjacent to or distant from the <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumour</z:e> </plain></SENT>
<SENT sid="8" pm="."><plain>CONCLUSIONS/INTERPRETATION: One or more factors released by human <z:e sem="disease" ids="C0017150" disease_type="Neoplastic Process" abbrv="">gastrinomas</z:e> increase beta cell replication in islets immediately adjacent to the <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumour</z:e>, but not in <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumour</z:e>-distant islets </plain></SENT>
<SENT sid="9" pm="."><plain>While these findings demonstrate that adult human beta cells can be driven into the cell cycle, they caution against the therapeutic usefulness of gastrin, since islets located &gt;1 cm away from the <z:e sem="disease" ids="C0017150" disease_type="Neoplastic Process" abbrv="">gastrinomas</z:e> did not exhibit changes in beta cell turnover, despite markedly elevated systemic gastrin levels sufficient to cause severe gastrointestinal symptoms </plain></SENT>
</text></document>